Imaging tests for post-treatment surveillance may come with radiation exposure, financial strain, “scanxiety” and sometimes unnecessary follow-ups. Doctors and patients need to balance the risks and benefits of scanning.

by Charlotte Huff

Precision medicine and immunotherapy offer opportunities for new treatments and clinical trials to patients who previously had few, if any, options.

by Kendall K. Morgan

Patient-reported outcomes may help shape the future of cancer care.

by Stephen Ornes

Healthy Habits

Too much time spent looking at electronic devices can come at a cost.

by Cameron Walker

Q&A

Hematologist-oncologist David Scadden traces the history, promise and uncertainties of treatment advances in Cancerland: A Medical Memoir.

by Marci A. Landsmann

Medical oncologist Leisha A. Emens discusses the significance of the first U.S. Food and Drug Administration approval of an immunotherapy treatment for breast cancer.

by Anna Azvolinsky

Patients diagnosed with low-risk prostate cancer are increasingly opting against immediate surgery or radiation in favor of regularly monitoring their disease.

by Jon Kelvey

A new survey suggests that young adults with colorectal cancer struggle to receive an accurate, prompt diagnosis.

by Bradley Jones

Broadening clinical trial eligibility criteria to include cancer patients who also have other health conditions could increase trial enrollment.

by Ashley P. Taylor

A study investigates whether a commonly used clinical trial endpoint, progression-free survival, can be used to predict quality of life.

by Jon Kelvey